academic article

• Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitis..  Journal of orthopaedic research : official publication of the Orthopaedic Research Society.  39:426-437. 2021
• Contemporary clinical isolates of Staphylococcus aureus from pediatric osteomyelitis patients display unique characteristics in a mouse model of hematogenous osteomyelitis..  Infection and immunity.  :-. 2021
• Measurement of Osteoblast Cytotoxicity Induced by S. aureus Secreted Toxins..  Methods in molecular biology (Clifton, N.J.).  2341:141-152. 2021
• Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus Osteomyelitis..  Antimicrobial agents and chemotherapy.  64:-. 2020
• Host nutrient milieu drives an essential role for aspartate biosynthesis during invasive Staphylococcus aureus infection..  Proceedings of the National Academy of Sciences of the United States of America.  117:12394-12401. 2020
• Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review..  Frontiers in microbiology.  11:-. 2020
• MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis..  PLoS pathogens.  15:-. 2019
• Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis..  Expert review of anti-infective therapy.  15:851-860. 2017